Matches in Wikidata for { <http://www.wikidata.org/entity/Q91869595> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q91869595 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q91869595 description "scientific article published on 18 March 2019" @default.
- Q91869595 description "wetenschappelijk artikel" @default.
- Q91869595 description "наукова стаття, опублікована 18 березня 2019" @default.
- Q91869595 name "Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial" @default.
- Q91869595 name "Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial" @default.
- Q91869595 type Item @default.
- Q91869595 label "Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial" @default.
- Q91869595 label "Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial" @default.
- Q91869595 prefLabel "Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial" @default.
- Q91869595 prefLabel "Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial" @default.
- Q91869595 P1433 Q91869595-9C1F8501-1FF3-41D5-B7D1-3CCA2FDAE2F8 @default.
- Q91869595 P1476 Q91869595-D96BB2CB-319B-42F8-A0E1-F53E4A458AFA @default.
- Q91869595 P2093 Q91869595-0BA96A90-E2B0-4054-9B98-5BBE93DD45DF @default.
- Q91869595 P2093 Q91869595-41FC1376-BAFC-4514-85F5-4588E5084452 @default.
- Q91869595 P2093 Q91869595-51937AC4-9F42-47DA-994E-AEBBADA5E15A @default.
- Q91869595 P2093 Q91869595-5B7EB884-FF3D-47FF-A1AF-CE1B3FDC51F0 @default.
- Q91869595 P2093 Q91869595-707DEE5E-45A5-454E-868B-99A97C4EBF4E @default.
- Q91869595 P2093 Q91869595-AC9D68F1-9C5B-499E-AB81-1EEE1A56B103 @default.
- Q91869595 P304 Q91869595-F9142DF3-271C-4292-8799-822519FD09A2 @default.
- Q91869595 P31 Q91869595-99E48F01-D947-4333-8A3E-4A9EEED0C279 @default.
- Q91869595 P356 Q91869595-606A6185-A02A-4799-935D-0B0C1A9288FC @default.
- Q91869595 P433 Q91869595-22B6B081-B9DC-4D67-9ABB-1DD0A689120B @default.
- Q91869595 P478 Q91869595-B86E7B87-8D45-4449-B8A3-F961DF55528B @default.
- Q91869595 P50 Q91869595-898E7009-ADD0-428E-A180-3BCF98D4D396 @default.
- Q91869595 P50 Q91869595-C4026260-6A17-4484-A2D8-CE45EAF27EF7 @default.
- Q91869595 P577 Q91869595-7C5CCDCB-7054-4C22-AD0A-DE3B99FA69B1 @default.
- Q91869595 P698 Q91869595-1268AE27-834E-46CA-9B2D-4577154C62FF @default.
- Q91869595 P921 Q91869595-6a531ebd-48ce-ff61-d28d-2dee7f47d528 @default.
- Q91869595 P356 09546634.2019.1587146 @default.
- Q91869595 P698 30799638 @default.
- Q91869595 P1433 Q6295084 @default.
- Q91869595 P1476 "Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial" @default.
- Q91869595 P2093 "Andreas Pinter" @default.
- Q91869595 P2093 "Baojin Zhu" @default.
- Q91869595 P2093 "David Shrom" @default.
- Q91869595 P2093 "Mark Lomaga" @default.
- Q91869595 P2093 "Martin Dossenbach" @default.
- Q91869595 P2093 "Wei Shen" @default.
- Q91869595 P304 "141-146" @default.
- Q91869595 P31 Q13442814 @default.
- Q91869595 P356 "10.1080/09546634.2019.1587146" @default.
- Q91869595 P433 "2" @default.
- Q91869595 P478 "31" @default.
- Q91869595 P50 Q57038615 @default.
- Q91869595 P50 Q61138924 @default.
- Q91869595 P577 "2019-03-18T00:00:00Z" @default.
- Q91869595 P698 "30799638" @default.
- Q91869595 P921 Q13574436 @default.